Chemical Compound
Androst-4-en-3-one, 4,17-dihydroxy-17-methyl-, (17ss)-; Androst-4-en-3-one, 4,17ss-dihydroxy-17-methyl- (6CI,8CI); 4,17ss-Dihydroxy-17-methylandrost-4-en-3-one; 4,17ss-Dihydroxy-17a-methylandrost-4-en-3-one; 4-Hydroxy-17-methyltestosterone; 4-Hydroxy-17a-methyltestosterone; Anamidol; Aranabol; NSC 45048; Oranabol; Oxymesterone; Oxymestrone; Theranabol
CAS Registry Number
145-12-0
Primary record
Androst-4-en-3-one, 4,17-dihydroxy-17-methyl-, (17ss)-; Androst-4-en-3-one, 4,17ss-dihydroxy-17-methyl- (6CI,8CI); 4,17ss-Dihydroxy-17-methylandrost-4-en-3-one; 4,17ss-Dihydroxy-17a-methylandrost-4-en-3-one; 4-Hydroxy-17-methyltestosterone; 4-Hydroxy-17a-methyltestosterone; Anamidol; Aranabol; NSC 45048; Oranabol; Oxymesterone; Oxymestrone; Theranabol
- 库存
- 6,158 克
- 纯度
- 99.1 %
- CAS
- 145-12-0
化合物标识与属性
- CAS
- 145-12-0
- PubChem CID
- 72061
- SMILES
- C[C@]12CCC(=O)C(=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C)O
- Canonical SMILES
- C[C@]12CCC(=O)C(O)=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O
名称与同义词
- Oxymesterone
- Anamidol
- Oranabol
- Theranabol
- Oxymestrone
- Oximesterona
- Aranabol
- Ossimesterone
- Oxymesteronum
- Oximesteronum
- Balnimax
- oxymesteron
- Oranabol 10
- methandrostenediolone
- Ossimesterone [DCIT]
- 4R73K9MRMX
- UNII-4R73K9MRMX
- Oxymesteronum [INN-Latin]
- Oximesterona [INN-Spanish]
- RefChem:169053
- OXYMESTERONE [MI]
- OXYMESTERONE [INN]
- 4-Hydroxy-17-methyltestosterone
- 145-12-0
- Oxymesterone [INN:BAN:DCF]
- AC1L2HC1
- AC1Q6OJ5
- 4-Hydroxy-methyltestosterone
- NSC-45048
- OXYMESTERONE [MART.]
- OXYMESTERONE [WHO-DD]
- SCHEMBL141603
- DTXSID80878527
- Oxymesterone [BAN:DCF:INN]
- DEA No. 4000
- CHEMBL1908006
- CHEBI:34903
- EINECS 205-646-9
- 4-Hydroxy-17a-methyltestosterone
- NSC 45048
- RXXBBHGCAXVBES-XMUHMHRVSA-N
- DTXCID901016572
- C20H30O3
- CID72061
- NSC45048
- ZINC4217232
- 4-Hydroxy-17alpha-methyltestosterone
- AR-1H7276
- Testosterone, 4-hydroxy-17-methyl-
- C20-H30-O3
- J5.832G
- MSK011102-100A
- 4-Hydroxy-17.alpha.-methyltestosterone
- Oxymesterone (1 mg/ml in Acetonitrile)
- 4,17beta-Dihydroxy-17-methylandrost-4-en-3-one
- AN-43963
- Oxymesterone (1.0mg/ml in Acetonitrile)
- 4,17beta-Dihydroxy-17alpha-methylandrost-4-en-3-one
- NS00041509
- 4,17.beta.-Dihydroxy-17-methylandrost-4-en-3-one
- 4,17b-Dihydroxy-17-methylandrost-4-en-3-one
- C14665
- 4,17|A-Dihydroxy-17-methylandrost-4-en-3-one
- 4,17b-dihydroxy-17-methyl-Androst-4-en-3-one
- 4,17b-Dihydroxy-17a-methylandrost-4-en-3-one
- Oxymesterone Solution in Acetonitrile, 100ug/mL
- 145O120
- (8R,9S,10R,13S,14S,17S)-4,17-dihydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
- 17alpah-methyl-4, 17beta-dihydroxy-androst-4-ene-3-one
- 17Alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene
- 4,17beta-Dihydroxy-17-methylandrosta-4-ene-3-one
- Androst-4-en-3-one,17.beta.-dihydroxy-17-methyl-
- (17S)-4,17-Dihydroxy-17-methylandrost-4-en-3-one
- 17alpha-Methyl-4,17beta-dihydroxyandrost-4-en-3-one
- Q10859626
- (17|A)-4,17-Dihydroxy-17-methyl-androst-4-en-3-one
- (17b)- 4,17b-dihydroxy-17-methyl-Androst-4-en-3-one
- 4,17.BETA.-DIHYDROXY-17-METHYLANDROST-4-EN-3-ONE.
- Androst-4-en-3-one,17-dihydroxy-17-methyl-, (17.beta.)-
- (1S,2R,10R,11S,14S,15S)-6,14-dihydroxy-2,14,15-trimethyltetracyclo(8.7.0.0^(2,7).0^(11,15))heptadec-6-en-5-one
- (1S,2R,10R,11S,14S,15S)-6,14-dihydroxy-2,14,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
- (1S,3aS,3bR,9aR,9bS,11aS)-1,6-dihydroxy-1,9a,11a-trimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one
- 1471-56-3
- 205-646-9
- Androst-4-en-3-one, 4,17-dihydroxy-17-methyl-, (17ss)-; Androst-4-en-3-one, 4,17ss-dihydroxy-17-methyl- (6CI,8CI); 4,17ss-Dihydroxy-17-methylandrost-4-en-3-one; 4,17ss-Dihydroxy-17a-methylandrost-4-en-3-one; 4-Hydroxy-17-methyltestosterone; 4-Hydroxy-17a-methyltestosterone; Anamidol; Aranabol; NSC 45048; Oranabol; Oxymesterone; Oxymestrone; Theranabol